semaglutide and multiple sclerosis New in the August 14, 2025, issue of NEJM: ⁣ ⁣ Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial)⁣ ⁣ Cagrilintide– for Overweight Diabetes (REDEFINE 2 phase 3a trial)⁣ ⁣ Glucagon-like peptide-1 agonist safety and

Sibling comparisons allow us to control for familial characteristics that might explain an apparent relationship between acetaminophen use during pregnancy and risk of neurodevelopmental conditions. Using data from Swedens national health and prescription drug registers, the researchers gathered data on medication use throughout pregnancy for births from 1995 to 2019

270 For example, ci-Ins2 is a conserved intronic circRNA derived from insulin pre-mRNA that exhibits lower levels in the islets of rodents and humans with type 2 diabetes

The GLP-1 RA MDL is still accepting new claims

Ethics declarations Competing interests K.B

SamirHNyameteasePElbadawyMFathiMMandourASRadwanFet al